MedDRA and Ontology. Anna Zhao-Wong, MD, PhD Deputy Director MedDRA MSSO

Similar documents
This Drug May Cause. The use of MedDRA in Clinical Trials and Pharmacovigilance

MedDRA Overview 3/18/2016

MedDRA Overview 3/16/2017

Role of MedDRA in Healthcare. MedDRA trademark is owned by IFPMA on behalf of ICH

What s New with MedDRA Version 21.0 and the MSSO

MedDRA Coding Basics

MedDRA Coding Basics

Standardised MedDRA Queries (SMQs)

Standardised MedDRA Queries (SMQs)

Standardised MedDRA Queries (SMQs) MedDRA trademark is owned by IFPMA on behalf of ICH

Standardised MedDRA Queries (SMQs)

Annual report 2011 Clinical trials of medicines in humans

GUIDANCE DOCUMENT FOR MARKETING AUTHORISATION HOLDERS ON SUBMISSIONS of PSURs UNDER THE EU PSUR WORK SHARING SCHEME. Version 10 November 2009

MedDRA Evolution. Desktop Browser. Medication Error Terms. First SMQs in Use. August March March 2005

Official Letter from DOH

MedDRA Evolution. August 1999 Desktop Browser. March 2005 Medication Error Terms. March 2005 First SMQs in Use

Blue Ribbon Panel 8 - Scope of MedDRA. Background

Update on New MedDRA SOC Product issues

IBI Health and Productivity Benchmarking

Sonja Brajovic Medical Officer, Office of Surveillance and Epidemiology Center for Drug Evaluation and Research Food and Drug Administration

The Utilization of Standardised MedDRA Queries in Marketing Applications and their

Pilot Study Concept Paper 1 Executive Summary. 2 Introduction. 2.1 Background: 2.2 Issue. MedDRA MSSO

How to Increase Drug Safety. Evolutions in Pharmacovigilance and Risk Management.

Frequently Asked Questions

The use of EudraVigilance: perspective from a NCA

Published by MedDRA MSSO for our Users March 2017

The Physician Advisor's Role in CDI Boot Camp

The Physician Advisor's Role in CDI Boot Camp

Introduction to the Identification of Medicinal Products ( IDMP)

UNDERGRADUATE AND PROFESSIONAL MAJOR CHANGE BULLETIN NO. 9 Spring Faculty Senate Approved April 11, COURSES---

9. EEA Qualified Pharmacy Technician Assessment Framework

International Foundations of Medicine Basic Science Exam Blueprint

Certified Coder Boot Camp Inpatient Version

Certified Coder Boot Camp Inpatient Version

Building A Knowledge Base of Severe Adverse Drug Events Based On AERS Reporting Data Using Semantic Web Technologies

BRP 8 recommendations MedDRA Management Board review and outcome 27th SOC

ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: 08/04/2013. ClinicalTrials.gov ID: NCT

Clinical Documentation Improvement Boot Camp

Clinical Documentation Improvement Boot Camp

FINAL DOCUMENT. Global Harmonization Task Force. Title: Clinical Evidence for IVD medical devices Key Definitions and Concepts

Clinical Documentation Improvement Boot Camp

Clinical Documentation Improvement Boot Camp

E2B, Safety databases & Eudravigilance

Belgium, a European leader in clinical trials

SERIOUS ADVERSE EVENTS

Proactivity Proposals

Proactivity Proposals

MedDRA TERM SELECTION: POINTS TO CONSIDER

Senior Regulatory Affairs Executive AREAS OF EXPERTISE

Radiography Curriculum Analysis

Biotech / Life Science Sector

ISTINYE UNIVERSITY FACULTY OF MEDICINE DEPARTMENT OF MEDICINE (ENGLISH) COURSE DESCRIPTIONS

IBM Watson for Medical Coding

CLINICAL TRIALS IN JORDAN: Current Status and Improvement Opportunities. Performing research under conditions of robust

CDISC Controlled Terminology across the Clinical Trial Continuum. Bay Area Implementation Network 6 March 2008

ICD Revision Process: Beta Phase and Finalization

Semantic Enrichment and the Information Manager

Pharmacovigilance information for pharmaceutical companies

School of Allied Medical Sciences. Course Description Guide Associate in Medical Laboratory Sciences. Page 1 of 15

SNOMED CT in the Age of Precision Medicine

IMI2: Strategic research agenda and overall approach Hugh Laverty Senior Scientific Project Manager

Initiatives to Speed up Data Mining. Ségolène Aymé ICORD 2014, Ede, Netherlands 9 October 2014

EMEA/AD/258: Head of Sector Pharmacovigilance and Risk Management of Medicinal Products for Human Use (AD9).

Signal Detection Quantitative Analysis of Safety Data. Dr. Yusuf Tanrikulu Basel, 29th November 2016

Flexible NLP for Varied Applications and Data Sources. David Milward, PhD CTO, Linguamatics

Published by MedDRA MSSO for our Users September 2015

Pharmacovigilance information for pharmaceutical companies

Identifying natural health product and dietary supplement information within adverse event reporting systems

LOINC in Regulated Clinical Research a Lab LOINC Steeringg Committee Meeting 08 June 2017

Pharmacovigilance in 2020: Boldly Shaping the Future An overview

Has no real or apparent conflicts of interest to report.

How to Construct an Optimal Interim Report: What the DMC Does and Doesn t Need to Know

OMICS Group. Contact us at:

Regulations of Biologics in Taiwan

The PROTECT project. ISoP 10 th Annual Meeting, 3-6 November 2010, Accra, Ghana. Presented by: Peter Arlett

Why developing an orphan drugs registry?

Microbiology An Introduction Tortora Funke Case Eleventh Edition

Introduction to Human Biology Human Biology

Supplementary exam work (Number, form, scope) Courses (type of teaching) Contact time. Winter semester

MedDRA TERM SELECTION: POINTS TO CONSIDER

From IMI to IMI2 new models of collaborative research. Magda Chlebus, Science Policy, EFPIA Ljubljana, 23 May 2014

Supplementary exam work (Number, form, scope) Courses (type of teaching) Contact time. Winter semester

THERAPEUTIC AREAS CARDIOVASCULAR RESEARCH

Current Development of Medical Terminology

EXPERT COLLECTION. Explore our leading medical review series

CAR T-cell therapy Registries Workshop

Traceability of biopharmaceuticals in spontaneous reporting systems

Principles of Medicine Block

MEANINGFUL USE CRITERIA PHYSICIANS

Solutions. to Manage Absenteeism and Impact Productivity. Prepared by Aon Hewitt. Tuesday, December 13, 2011

E2B(R3): THE INSIDE SCOOP FOR PRODUCT SAFETY TEAMS IN LIFE SCIENCES

Doctor of Pharmacy Course Descriptions

The PROTECT project An Innovative Public-Private Partnership for New Methodologies in Pharmacovigilance and Pharmacoepidemiology

Biomarkers: Dynamic Tools For Health And Safety Risk Assessments

See Important Reminder at the end of this policy for important regulatory and legal information.

Mircea Ciuca, MD Global Head Medical & Clinical Drug Safety

IBM Micromedex care delivery Evidence-based clinical decision support for healthcare decision-makers

No. Classification Credit Actual Hour/s. 1 Theoretical Component Lab. Component Clinical Component 1 3. Foundation Program

Challenges in Capturing Long Term Follow up of Recipients of Genetically Modified Cells. Cell Therapy Liaison Meeting January, 2018

Transcription:

MedDRA and Ontology Anna Zhao-Wong, MD, PhD Deputy Director MedDRA MSSO anna.zhao-wong@meddra.org

What is MedDRA? Med = Medical D = Dictionary for R = Regulatory A = Activities 2

What Is MedDRA Used For? To support registration, documentation & safety monitoring of medicinal products, by providing: Standardised communication between industry and regulators Within regions and between regions Support for electronic submissions Individual Case Safety Report (ICSR) Electronic Common Technical Document (ectd) Improvements in the quality and timeliness of data available for effective analysis, exchange and decision making 3

Who Are MedDRA Users? Regulatory authorities US FDA Europe: EMA and National Competent Authorities MHLW (Japan) And others Biopharmaceutical industry Academic and research institutions Clinical research organizations Other organizations dedicated to public health 4

Governance of MedDRA 5

Structure of MedDRA MedDRA Scope is defined and its structure is designed specifically for its purpose To support registration, documentation & safety monitoring of medicinal products 6

Scope of MedDRA Standardized medical terminology to facilitate sharing of regulatory information internationally for medical products used by humans In the context of MedDRA, "product" can refer to various types of products intended for humans Drugs (prescription and over the counter) Biologics Vaccines Combination products Devices Nutraceuticals Dietary supplements Reference MedDRA Introductory Guide, Appendix B Concept Descriptions in MedDRA 7

Scope of MedDRA (cont) 8

MedDRA Hierarchical Structure System Organ Class (SOC) (26) High Level Group Term (HLGT) (334) Standardised MedDRA Queries (SMQs) (96) High Level Term (HLT) (1,720) Preferred Term (PT) (20,808) Lowest Level Term (LLT) (73,221) MedDRA Version 17.1 9

MedDRA System Organ Classes Blood and lymphatic system disorders Cardiac disorders Congenital, familial and genetic disorders Ear and labyrinth disorders Endocrine disorders Eye disorders Gastrointestinal disorders General disorders and administration site conditions Hepatobiliary disorders Immune system disorders Infections and infestations Injury, poisoning and procedural complications Investigations Metabolism and nutrition disorders Musculoskeletal and connective tissue disorders Neoplasms benign, malignant and unspecified (incl cysts and polyps) Nervous system disorders Pregnancy, puerperium and perinatal conditions Psychiatric disorders Renal and urinary disorders Reproductive system and breast disorders Respiratory, thoracic and mediastinal disorders Skin and subcutaneous tissue disorders Social circumstances Surgical and medical procedures Vascular disorders 10

MedDRA Hierarchy Example SOC = Cardiac disorders HLGT = Cardiac arrhythmias HLT = Rate and rhythm disorders NEC PT = Arrhythmia LLT LLT Arrhythmia LLT Dysrhythmias NOS Arrhythmia LLT (Non-current) Other specified cardiac MSSO-DI-6017-17.0.0 11 dysrhythmias

A Multi-Axial Terminology Multi-axial = the representation of a medical concept in multiple SOCs Allows grouping by different classifications Allows retrieval and presentation via different data sets Purpose of Primary SOC Determines which SOC will represent a PT during cumulative data outputs Is used to support consistent data presentation for reporting to regulators 12

A Multi-Axial Terminology (cont) SOC = Respiratory, thoracic and mediastinal disorders SOC = Infections and infestations HLGT = Respiratory tract infections HLGT = Viral infectious disorders HLT = Viral upper respiratory tract infections HLT = Influenza viral infections PT = Influenza 13

MedDRA SMQs SMQs are MedDRA analytical tools Groupings of terms from one or more MedDRA System Organ Classes (SOCs) related to defined medical condition or area of interest Included terms may relate to signs, symptoms, diagnoses, syndromes, physical findings, laboratory and other physiologic test data, etc., related to medical condition or area of interest Aid in case identification and signal detection MSSO-DI-6246-17.0.0 14

MedDRA Hierarchy with SMQs Example SOC = Cardiac disorders SMQ = Cardiac arrhythmia terms, nonspecific HLGT = Cardiac arrhythmias HLT = Rate and rhythm disorders NEC SMQ = Cardiomyopathy PT = Arrhythmia LLT Arrhythmia NOS LLT Arrhythmia LLT Dysrhythmias LLT (Non-current) Other specified cardiac dysrhythmias 15

SMQs in Production - Examples As of Version 17.1, a total of 96 in production Agranulocytosis Anaphylactic reaction Cerebrovascular disorders Convulsions Depression and suicide/self-injury Hepatic disorders Hypersensitivity Ischaemic heart disease Lack of efficacy/effect Osteonecrosis Peripheral neuropathy Pregnancy and neonatal topics Pseudomembranous colitis Rhabdomyolysis/myopathy Severe cutaneous adverse reactions Systemic lupus erythematosus MSSO-DI-6246-17.0.0 16

Maintenance Rigorous maintenance through a change request process including international medical review MSSO and JMO started operations in late 1998 First release was MedDRA 2.1 in March 1999 Maintenance rules were established and made available to users 17

MedDRA Evolution Growth of ~26K terms in 14 years MedDRA 2.1 March 1999 MedDRA 16.1 September 2013 18

MedDRA Evolution (cont.) March 1999 September 2014 Distributed on CD or Diskette Web distribution No regulatory requirements Mandated by law or practice No coding or analysis guidance available Points to Consider documents for coding and analysis 9 Special Search Categories Big effort to convert people, systems, and databases 96 Standardised MedDRA Queries (SMQs) are available MedDRA is an international standard 19

Pharmacovigilance Data Sources Expanding to sources of observational data (big data analysis) Past Data Source Present and Future Data Source Drug Safety Data (MedDRA) Payer Data (ICD) e-health Record data (SNOMED CT) 20

Interoperability of MedDRA Big data analysis a use case of MedDRA s interoperability with others MEDLINE (MeSH) Payer data (ICD-9-CM) e-health data (SNOMED CT) Clinical trial and post-market surveillance (MedDRA) Interoperability with other medical terminologies In UMLS, MedDRA terms are linked to terms of other terminologies under the same ConceptID Terminologies: ICDs, SNOMED CT Mappings extracted from UMLS need substantial manual curation Could the implementation of MedDRA in an ontological framework improve the accuracy of the mappings? If so, how? 21

Facilitating Data Retrieval and Analysis Defining a clinical event of interest by a group of relevant MedDRA terms Example: SMQs A definition term list The clinical event can be A drug safety concern A labeled event 22

Facilitating Data Retrieval and Analysis The definition term list of the clinical event helps To retrieve relevant cases in drug safety surveillance and pharmacovigilance To identify if a newly reported event is labeled or unlabeled Can adding ontological features to MedDRA help to create quality definition term lists in MedDRA? If so, how? 23

Enhancing MedDRA Translations MedDRA translations MedDRA is available in 11 languages including English English MedDRA is the master file Other languages are the mirror translation of English master Challenge: non-english language may have more synonyms of a concept than English Adding concept IDs in MedDRA offers the placeholders for synonyms unique to a particular language 24

Questions?